Clinical Trial Update: Comparison of I.V. CTAP201 and Doxercalciferol (Hectorol) in Subjects With Chronic Kidney Disease (CKD) and Secondary Hyperparathyroidism (SHPT) [Phase 1]

View source ↗

Summary

This Phase 1 trial compares intravenous CTAP201 with doxercalciferol (Hectorol) in subjects with chronic kidney disease and secondary hyperparathyroidism; the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hyperparathyroidism

Drugs mentioned

• CTAP201
• Hectorol (doxercalciferol)

Snippet

Sponsor: OPKO IP Holdings II, Inc. | Conditions: Chronic Kidney Disease, Secondary Hyperparathyroidism | Phase 1 | Status: COMPLETED